The Daily

Gilead is buying Munich-based Tubulis for $3.15B upfront plus up to $1.85B in milestones, leaning even harder into antibody–drug conjugates (ADCs). The anchor asset is TUB-040, a NaPi2b-directed topoisomerase‑I inhibitor ADC in phase 1b/2 for platinum‑resistant ovarian cancer and NSCLC. Tubulis reported a 59% overall response rate in PROC last year and has been outlining a quick path toward pivotal trials. The implication: Gilead wants not just “an ADC,” but an ADC platform it believes can widen the therapeutic window — and it’s willing to pay for speed.

Sanofi’s TSLP/IL‑13 inhibitor lunsekimig hit the primary endpoint in the phase 2b Aircules asthma study, showing a statistically significant reduction in exacerbations after 48 weeks. It also reduced nasal polyps over 24 weeks in the phase 2a Duet trial in chronic rhinosinusitis. But the phase 2b Velvet atopic-dermatitis trial missed its primary endpoint (Sanofi is holding the full dataset for upcoming congresses). Net: the dual‑target mechanism still looks real for respiratory inflammation — but it’s not a guaranteed “Dupixent successor” story.

Endpoints reports BioNTech will close its Singapore operation in a streamlining move — a reminder that the post‑pandemic mRNA footprint is still being resized. The detail to watch is strategic, not sentimental: the site was acquired from Novartis a little over three years ago, and it now sits inside a broader operational review. For BioNTech, this is about concentrating manufacturing and management attention on nearer-term platform bets. For everyone else, it’s a signal that “global presence” is being re-priced against utilization and pipeline certainty.

Reuters: Intel will join Elon Musk’s Terafab AI chip project with SpaceX and Tesla, positioning itself inside a very Musk-ish plan: two advanced chip factories in Austin, Texas — one for cars and humanoid robots, one for “AI data centers in space.” Intel says the partnership helps Terafab’s stated goal of producing 1 terawatt per year of compute for future AI/robotics. For Intel, the timing matters: its Foundry unit posted an operating loss of $10.32B in 2025, so marquee customers and headline-scale projects double as credibility fuel. The bet: manufacturing relevance via “must-ship” demand, not hype.

TNW spotted a low-key launch with outsized implications: Google AI Edge Eloquent, a free iOS dictation app that runs transcription offline-first (on-device) and strips filler words automatically. It appeared in the App Store on 6 April 2026 with no press release, no subscription, and no usage caps. The product move here is simple: make “voice-to-clean-text” cheap and private enough to be default behavior. If this holds up, a chunk of the $15/month dictation-app market just got squeezed.

Ars Technica covers US PIRG’s “Failing the Fix (2026)” report, which grades laptop and smartphone repairability using French/EU scoring frameworks and a disassembly-weighted methodology. Apple comes out worst in the pack with a C‑minus for laptop repairability and a D‑minus for phones. One nerdy but important detail: PIRG’s scoring also penalizes companies for membership in lobbying groups opposing right-to-repair legislation, and rewards explicit support for R2R bills. The implication for the AI era: as devices become more model‑dependent, the repair ecosystem becomes part of “who controls the stack.”

Solid tumors keep embarrassing CAR‑T partly because effective immune cells don’t infiltrate well — and because the “immune coordination layer” is missing. A new Biomaterials paper proposes an intratumoral workaround: an injectable scaffold made of oppositely charged hydrogel microparticles, designed to mimic tertiary lymphoid structures. The construct encapsulates immune‑stimulating cytokines and physically co‑locates T cells and B cells, supporting sustained T‑cell expansion/activation after injection. In several tumor models, the approach suppressed local tumors and showed abscopal effects against distant tumors versus conventional CAR‑T. The interesting implication: the “delivery format” may matter as much as the receptor.

In a cohort of 198 multiple-myeloma patients treated with ide‑cel or cilta‑cel (June 2021–Dec 2024), 27 patients (13.6%) developed CAR‑T therapy-associated immune‑related adverse events (CirAEs) like cranial nerve palsy, parkinsonism, or enterocolitis. One standout case had extreme CD4+ CAR‑T expansion with peak lymphocytes at 197 × 10^3/μL; in vitro, the expansion was abrogated by CCR5 inhibition. CirAEs correlated with higher non‑relapse mortality (hazard ratio 5.2; P = 0.006) and risk factors included peak ALC ≥ 2.4 × 10^3/μL in the first 14 days. Translation: CD4 dynamics aren’t just “interesting biology” — they may be a clinical lever.

Oregon State researchers report lipid nanoparticles that bind vitronectin in blood, then home to lung tumors via overexpressed integrin receptors. In a mouse model, the LNPs delivered follistatin mRNA, cutting tumor burden with an approximately 2.5‑fold greater reduction versus conventional LNP approaches that often end up in the liver. The same payload also targets cachexia biology, aiming to blunt muscle wasting alongside anti-tumor activity. The hard part — systemic delivery of mRNA therapeutics to lung tumors — is exactly what this claims to improve.

If you want a Venice trip that isn’t just queues + photos: Venezia Unica has the dates for Bloom Venice Festival at Parco San Giuliano — April 24–26 and April 29–May 3, 2026. It’s a clean “bookend” idea: you can anchor two shorter long-weekend runs around the festival windows and keep the in‑between days for islands / Biennale spillover without treating the city like a checklist. Practical implication: in April/early May, Venice rewards plans built around one fixed event and lots of loose time.

Visit Puglia’s Bari events overview is more “orientation” than breaking news — but that’s exactly the point when you’re planning: it surfaces the recurring anchors (trade fairs, street-food festivals, jazz, film) so you can time a trip around one high-signal week. If Venice feels too intense, Bari works as a base with easy day trips (Polignano a Mare, Alberobello, coast). The implication is planning efficiency: pick the one festival you care about, then fill the rest with beaches/food instead of transport friction.

Kurzliste: Start Festwochen (ab 15.5.) · MAK-Schlingensief-Ausstellung (ab 13.5.) · Patti Smith (21.5. Konzert, 22.5. Eröffnung am Heldenplatz) · Castellucci „Credere alle Maschere“ (6.–7.6., Halle G) · „Parsifal“-Neudeutung (ab 15.6., Halle E)
Der ORF fasst das Programm zum 75‑Jahr‑Jubiläum kompakt zusammen: Milo Rau kuratiert weiter auf „mythisch/gegenwärtig“, mit großen Namen (Castellucci, Wilson posthum) und Pop‑Gewicht (Patti Smith, 79). Das Praktische für die Planung: viele Fixtermine sind bereits klar datiert, und es sollen rund 50.000 Tickets in den Verkauf gehen, plus etliche Projekte bei freiem Eintritt. Wenn man nur einen Abend picken will: 21./22. Mai ist die dichte Kombination.

Die Stadt Wien konkretisiert das Ring-Projekt: Der Auftakt soll am inneren Schottenring zwischen Schottentor und Schottenring starten — rund 700 m, geplanter Baustart Herbst 2026 (nach Wasserleitungsarbeiten). Die Nebenfahrbahn wird zur „Rad‑Allee“ mit großteils baulich getrennten 4,50 m breiten Zwei‑Richtungs‑Radwegen bzw. Fahrradstraßen; dazu sind >900 m² neue Grünflächen/Beete und 12 neue Bäume in diesem Abschnitt genannt. Heute und morgen (8./9. April) gibt’s eine Planungsausstellung im Ringturm (16:30–19:30) — wer die Renderings sehen will, jetzt.

Bleacher Report’s snapshot after April 7 is basically the vibe of the last week of the season: the field is mostly set, but the middle is violent. The key date: postseason play begins April 14 with the Play-In tournament (seeds 7–10). In the West, B/R flags a tight race between the Nuggets, Lakers and Rockets for the 3/4/5 slots — and the strategic prize is obvious: avoid a brutal bracket path and keep home court. The implication: one bad back-to-back can change your entire playoff geometry.

ESPN’s recap has the clean headline line: Nikola Jokic put up 40 points, 13 assists and 8 rebounds as Denver beat San Antonio 136–134 in overtime. Wembanyama countered with a monster line (including 18 rebounds) as the Spurs’ 11-game win streak snapped. In April, these games are less “regular season” and more “stress test”: half-court possessions, foul management, and the two guys who can manufacture a shot under pressure deciding it.

The NBA’s own nightly recap is the best low-friction way to keep your context straight when there are double-digit slates. This one bundles 11 games and leans into the “April is chaos” theme — big performances, weird rotations, and the kind of momentum swings teams carry into the Play‑In week. Useful if you don’t have time for full recaps but want to see who looks sharp rather than just who won.

Kurzliste: 22.–26.6. Festivalwoche · Ensembles 14–24 Jahre · täglich mehrere Produktionen · Workshops + Gespräche + Open Stages
Dschungel Wien und das NEST holen im Juni junge Musiktheater- und Tanzensembles aus ganz Österreich ins Rampenlicht. Das ist nicht „Kinderprogramm“ im klassischen Sinn, sondern ein Format, das Familien mit älteren Kids/Teens abholt — mit Aufführungen und Austausch (Workshops, Gespräche, Partys). Wenn man für den Frühsommer einen Kulturtermin sucht, der nicht nach „Pflicht“ riecht: diese Woche klingt wie ein gutes Fenster.

Kurzliste: Stadtmodell bauen · „kinderfreundliche Stadt“ als Thema · Termine: 8.4., 15.4., 22.4., 29.4. (12:30–15:00)
WIENXTRA hat einen sehr brauchbaren, konkreten Workshop: Kinder planen spielerisch ihren idealen Lebensraum und setzen ihn mit Baumaterialien als Stadtmodell um. Das ist gleichzeitig Basteln und „wie funktioniert Stadt?“ — also perfekt, wenn man etwas sucht, das nicht nur bespaßt. Wichtig: Anmeldung erforderlich; heute ist sogar ein Termin.